United Therapeutics (UTHR) CEO sells shares under preset trading plan
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp (UTHR) Chairperson & CEO Martine Rothblatt, through a family trust, exercised 9,500 stock options at an exercise price of $135.42 per share into 9,500 shares of common stock on August 18, 2026, then sold 9,500 shares in multiple open-market trades at weighted average prices around the low-$500s per share. After the option exercise, the family trust held 113,410 stock options, and Rothblatt also reported 40,513 shares held directly and 166 shares held indirectly by spouse. All option exercises and related sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which covers up to 1,734,410 options expiring March 15, 2027, or runs until December 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.61M approx. pre-tax spread)
Exercise and Sale
17 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($4.90M)
Approx. gross sale proceeds
$4.90M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.61M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F16 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 239 | $509.4837 | $122K |
| Sale | Common Stock F1, F4, F2 | 231 | $510.4728 | $118K |
| Sale | Common Stock F1, F5, F2 | 170 | $511.5941 | $87K |
| Sale | Common Stock F1, F6, F2 | 439 | $513.0605 | $225K |
| Sale | Common Stock F1, F7, F2 | 1,264 | $514.1759 | $650K |
| Sale | Common Stock F1, F8, F2 | 2,333 | $514.9866 | $1.20M |
| Sale | Common Stock F1, F9, F2 | 1,880 | $516.0448 | $970K |
| Sale | Common Stock F1, F10, F2 | 873 | $517.089 | $451K |
| Sale | Common Stock F1, F11, F2 | 1,630 | $518.1853 | $845K |
| Sale | Common Stock F1, F12, F2 | 441 | $518.6476 | $229K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F13 | -- | -- | -- |
| holding | Common Stock F14 | -- | -- | -- |
| holding | Common Stock F15 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 113,410 shares (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (16)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $516.60 to $517.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $517.60 to $518.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $518.60 to $518.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F14. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F15. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F16. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $508.94 to $509.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $510.00 to $510.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $511.145 to $511.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $512.56 to $513.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $513.56 to $514.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $514.56 to $515.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $515.56 to $516.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options Exercised: 9,500 shares
Option Exercise Price: $135.42 per share
Shares Sold: 9,500 shares
+5 more
8 metrics
Options Exercised
9,500 shares
Stock options exercised into common stock on August 18, 2026
Option Exercise Price
$135.42 per share
Exercise price of stock options converted on August 18, 2026
Shares Sold
9,500 shares
Total UTHR common shares sold in multiple trades on August 18, 2026
Representative Sale Price
$514.99 per share
Weighted average price for 2,333 shares sold in one sale tranche
Options Remaining in Trust
113,410 options
Stock options held by a family trust after the reported exercise
10b5-1 Plan Pool
1,734,410 options
Maximum options to be exercised under the trading plan before March 15, 2027 or December 31, 2026
Direct Share Holdings
40,513 shares
Common stock held directly by Martine Rothblatt after the transactions
Indirect Spousal Holdings
166 shares
Common stock held indirectly by spouse as reported
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, family trusts
4 terms
Rule 10b5-1 trading plan regulatory
"This exercise of stock options and sale ... was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
family trusts financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
FAQ
What insider transactions did UTHR CEO Martine Rothblatt report on August 18, 2026?
On August 18, 2026, Martine Rothblatt’s family trust exercised 9,500 stock options of UNITED THERAPEUTICS Corp (UTHR) at $135.42 and received 9,500 common shares, then sold 9,500 shares in multiple open-market trades at weighted average prices in the low-$500s per share.
Were Martine Rothblatt’s August 18, 2026 UTHR trades made under a Rule 10b5-1 plan?
Yes. The option exercise and related UTHR share sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025. The plan continues until either 1,734,410 options are exercised or December 31, 2026, whichever occurs first.
How many UNITED THERAPEUTICS (UTHR) stock options does Martine Rothblatt’s family trust hold after these trades?
After the August 18, 2026 transactions, a family trust associated with Martine Rothblatt held 113,410 stock options on UTHR. These options, according to the disclosure, have an $135.42 exercise price and March 15, 2027 expiration, and are part of the broader 10b5-1 plan pool.
What is the exercise price and expiration date of the UTHR options exercised on August 18, 2026?
The 9,500 UNITED THERAPEUTICS (UTHR) options exercised on August 18, 2026 had an exercise price of $135.42 per share and an expiration date of March 15, 2027. These options converted into 9,500 common shares before the related open-market sales occurred.
AI-generated analysis. How Rhea-AI works. Not financial advice.
